Latest News

  • 22 Oct 2014

    TapImmune Provides Update on PolyStart™ Vaccine Platform A...

    Platform Technology is a novel platform for rapid development of Vaccines for Cancer and Multiple Emerging Viral Threats including Ebola, Enterovirus, and Smallpox.   SEATTLE, WASHINGTON, October 22, 2014 — TapImmune, Inc. (OTCBB: TPIV), provides an update on the status of its...

    more >

  • 11 Oct 2014

    Tapimmune, a Biotech Company Focused on Stimulating the Body...

    TapImmune, a biotech company focused on stimulating the body’s own immune system to fight cancer. Please listen to the interview with host Eric Michaels of eHealth Radio Network and TapImmune CEO Glynn Wilson...

    more >